(Q51679092)

9 April 2018

editorial

0 references

review article

1 reference

title

Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate. (English)

1 reference

9 April 2018

1 reference

1 reference

Marin H Kolleff

1

1 reference

9 April 2018

publication date

1 February 2003

1 reference

9 April 2018

published in

Intensive Care Medicine

1 reference

9 April 2018

volume

29

1 reference

9 April 2018

issue

2

1 reference

9 April 2018

page(s)

147-149

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1007/s00134-002-1614-x

exact match

0 references

cites work

Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

The quick and the dead: the importance of rapid evaluation of infiltrates in the immunocompromised patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Antibiotic resistance in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-002-1614-X

Pneumonia mortality reduction and quality improvement in a community hospital

21 January 2018

1 reference

12 December 2020

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia

1 reference

12 December 2020

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

12 December 2020

The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group

1 reference

12 December 2020

Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies

1 reference

12 December 2020

10.1007/S00134-002-1614-X

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

12675039

1 reference

9 April 2018